Symphogen Further Strengthens its Immuno-Oncology Pipeline by Advancing into Two Additional Clinical Trials
30 mai 2018 09h30 HE
|
Symphogen A/S
Symphogen Further Strengthens its Immuno-Oncology Pipeline by Advancing into Two Additional Clinical Trials Seventh Program to enter Clinical Development at Symphogen Symphogen’s antibody platform is...